NAYA Biosciences
Anna K. Baran-Djokovic currently serves as Senior Vice President of Investor Relations at NAYA Biosciences, a position held since October 2023. Previously, Anna was Vice President of Investor Relations & Capital Markets at Cytovia Therapeutics, where significant contributions were made in transitioning the company to public readiness. Anna's experience includes roles at ABLE Investor Relations, where comprehensive client communication strategies and investor roadshows were developed, and various investor relations positions at companies such as STEBA Biotech and IMMUNE Pharmaceuticals Inc. The tenure at IMMUNE Pharmaceuticals included senior leadership in corporate affairs and investor relations, focusing on relationships with investment bankers and raising visibility through media engagements. Prior experience also encompasses business development consulting for foreign entrepreneurs at Global Law Group. Anna holds a Master's Degree in Law from the University of Warsaw and has studied at the SGH Warsaw School of Economics.
This person is not in any teams
NAYA Biosciences
NAYA Biosciences is building a group of companies leveraging the next generation of biotechnologies to increase patient access to life-transforming treatments in oncology, fertility, and regenerative medicine. Our unique capabilities in biology, cell and gene therapy, and artificial intelligence provide a synergistic platform for the accelerated clinical development and commercialization of these breakthrough treatments.